Preventing Arthritis in a Multi-Center Psoriasis At-Risk Cohort
Latest Information Update: 20 Dec 2024
Price :
$35 *
At a glance
- Drugs Guselkumab (Primary) ; Antipsoriatics
- Indications Psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms PAMPA
- 17 Dec 2024 Planned number of patients changed from 350 to 176.
- 17 Dec 2024 Planned End Date changed from 1 Mar 2026 to 31 Jul 2028.
- 17 Dec 2024 Planned primary completion date changed from 31 Dec 2025 to 31 Dec 2026.